We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.29B
AUM Growth
-$122M
Cap. Flow
-$104M
Cap. Flow %
-8.05%
Top 10 Hldgs %
31.67%
Holding
282
New
11
Increased
30
Reduced
43
Closed
37

Sector Composition

Rank Sector Weight
1 Financials 34.2%
2 Healthcare 21.4%
3 Consumer Discretionary 9.38%
4 Industrials 6.44%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOGOW
226
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
$5K ﹤0.01%
100,000
SGIIW
227
DELISTED
Seaport Global Acquisition II Corp. Warrants
SGIIW
$5K ﹤0.01%
37,500
GIA.WS
228
DELISTED
GigCapital 5, Inc. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GIA.WS
$5K ﹤0.01%
200,000
IGTAW
229
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$4K ﹤0.01%
72,500
VSACW
230
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$4K ﹤0.01%
75,000
FRLAW
231
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$3K ﹤0.01%
50,000
COVAW
232
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$3K ﹤0.01%
125,000
VTIQW
233
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$3K ﹤0.01%
23,905
GSMGW
234
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$2K ﹤0.01%
225,000
ATA.WS
235
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$2K ﹤0.01%
75,000
PCXCW
236
DELISTED
Parsec Capital Acquisitions Corp Warrant
PCXCW
$2K ﹤0.01%
75,000
ALNY icon
237
Alnylam Pharmaceuticals
ALNY
$28.9B
-39,000
Closed -$5.69M
AMLX icon
238
Amylyx Pharmaceuticals
AMLX
$2.59B
-677,714
Closed -$13M
BURU
239
DELISTED
NUBURU INC
BURU
-15,030
Closed -$29.9M
COCH icon
240
Envoy Medical
COCH
$51.5M
-150,000
Closed -$1.47M
GM icon
241
General Motors
GM
$76.6B
-1,205,400
Closed -$44.2M
MSAI icon
242
MultiSensor AI
MSAI
$11M
-5,000
Closed -$1.99M
OBIO icon
243
Orchestra BioMed
OBIO
$253M
-10,000
Closed -$100K
PROK icon
244
ProKidney
PROK
$339M
-500,000
Closed -$4.97M
SLND icon
245
Southland Holdings
SLND
$34.2M
-200,000
Closed -$1.99M
TSVT
246
DELISTED
2seventy bio
TSVT
-210,000
Closed -$2.77M
TYGO icon
247
Tigo Energy
TYGO
$96M
-400,000
Closed -$3.97M
QTI
248
QT Imaging Holdings
QTI
$37.3M
-200,000
Closed -$2.01M
IGTA
249
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
-145,000
Closed -$1.43M
CLBTW
250
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
-172,950
Closed -$134K

Similar funds

683 Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, 683 Capital Management held 282 positions worth $1.29B, down 8.6% from $1.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

683 Capital Management withdrew a net $104M in Q3 2022, closing 37 positions and reducing 43 holdings. Its most notable exit was General Motors, an estimated $44.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in Builders FirstSource worth $23M.

  • 683 Capital Management's largest Q3 2022 buy was Builders FirstSource: 390,000 shares worth $23M.
  • 683 Capital Management added most to Capital One in Q3 2022, an estimated $13.8M increase.
  • 683 Capital Management's biggest Q3 2022 reduction was Syndax Pharmaceuticals, cutting an estimated $10.1M.
  • 683 Capital Management fully exited General Motors in Q3 2022, selling an estimated $44.2M.
  • 683 Capital Management's ten largest holdings make up 32% of its $1.29B portfolio in Q3 2022.
  • 683 Capital Management opened 11 new positions and closed 37 in Q3 2022.
  • 683 Capital Management's portfolio value fell 8.6% quarter-over-quarter to $1.29B.

Based on 683 Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.